Showing 1 - 2 results of 2 for search 'J. C. Byrd', query time: 0.02s Refine Results
  1. 1
    P525: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF ENTOSPLETINIB ADDED TO INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN NEWLY DIAGNOSED NPM1-MUTATED AML

    P525: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF ENTOSPLETINIB ADDED TO INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN NEWLY D... by J. C. Byrd, J. E. Cortes, M. D. Minden, T. Oellerich, E. M. Stein, J. Elder, P. Kumar, G. Bray, J. DiMartino, W. Stock

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY

    P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPAN... by J. Woyach, I. W. Flinn, F. T. Awan, H. Eradat, D. Brander, M. Tees, S. A. Parikh, T. Phillips, W. Wang, N. M. Reddy, M. Z. Farooqui, J. C. Byrd, D. M. Stephens

    Published 2022-06-01
    Get full text
    Article

Search Tools: